Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial.

The post Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• Wall Street Titan: Here’s My #1 Stock for 2023
• The $1 Investment You MUST Take Advantage of Right Now
• It doesn’t matter if you have $500 or $5 million. Do this now.